November 2022 FDA Recall Drug by Discovery Pharma Llc
D-0261-2023 - CGMP deviations

This Class II drug recall was voluntarily initiated by Discovery Pharma Llc on November 9, 2022 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in CA, FL, WA and the recall is currently terminated.

Recall Number: D-0261-2023

Reason for Recall
CGMP deviations
Initiated
11-09-2022
Reported
02-08-2023
Quantity
21,892 tubes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
DISCOVERY PHARMA LLC
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland

Batch or Lot Expiration Information

Lot# Lots: 22123 Exp. 01/2024; 21732 Exp. 07/2023